SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is trending as its community leverages high social engagement and steady, organic growth to push toward new market cap milestones. Supporters are actively discussing their long-term conviction in the project, emphasizing its transparency and community-driven approach as key differentiators in the memecoin market.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

The Buttcoin community is rallying behind a long-standing narrative that positions the token as a cultural counterpoint to traditional assets, driven by its 2011 origin story and status as an early pioneer in the parody coin space. Supporters are actively discussing a transition toward a more formal ecosystem, emphasizing the coin's historical persistence and growing adoption as primary catalysts for its future potential.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost is trending as community members debate its potential as a privacy-focused utility token on the Solana network versus persistent accusations of it being a pump-and-dump scheme. Discussions are polarized between investors promoting it as an undervalued gem with upcoming project milestones and critics labeling it a slow rug pull.

Invitation Homes, Inc. engages in the acquisition, renovation, leasing, and operation of single-family homes as rental properties, including single-family homes in planned unit developments. Its services include property management, selection of homes, maintenance program, and online payment. The company was founded by Marcus Ridgway, Dallas Tanner, and Brad Greiwe in 2012 and is headquartered in Dallas, TX.

Invitation Homes Inc

Invitation Homes is garnering attention as the broader housing sector faces intense scrutiny over the impact of institutional ownership on home affordability. Investors are closely monitoring its performance against a backdrop of potential policy shifts, fluctuating interest rates, and internal growth initiatives like new development partnerships.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to anticipation of the CHOPIN trial data, which is set to be presented as a late-breaking abstract at ESMO. While the community is frustrated by recent stock volatility and revenue guidance adjustments, sentiment remains highly focused on the potential for clinical trial success to expand the Hepzato Kit's standard-of-care position and drive long-term value.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating intense community interest due to its ultra-low circulating supply and potential for price appreciation within the NFT and DeFi sectors. Investors are actively discussing the possibility of a supply shock and a significant breakout, with many advocating for accumulation despite recent volatility and skepticism.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors highlight the project's 'phygital' strategy, noting its physical presence in major retail stores and the recent launch of a Visa-backed spending card. Community sentiment remains polarized, with many holders aggressively accumulating during price dips while others express frustration over the token's inability to decouple from broader market volatility.

WorldFinancial

WorldFinancial (WLFI) is seeing intense volatility and social media debate as investors react to a Congressional probe into the projects foreign investment deals and ongoing concerns regarding governance and transparency. While some community members view the current price action as an accumulation opportunity ahead of upcoming crypto forums and product milestones, others remain highly skeptical, labeling the token a speculative grift that heavily relies on the Trump family brand.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following an appeals court ruling that could significantly reduce its wildfire-related liabilities, while investors continue to debate the company's direction under new CEO Greg Abel. The community is actively discussing the stock's recent underperformance relative to the broader market, with many questioning the firm's capital allocation strategy and the long-term effectiveness of its massive cash pile.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is gaining significant traction on the Solana network, with the community highlighting its long-term project viability, consistent daily activity, and a voluntary supply-locking mechanism. Supporters are actively focused on the project's 'PvE' narrative, emphasizing deep conviction, doxxed leadership, and steady growth over short-term hype.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Lowers Emergent Biosolutions (NYSE:EBS) Price Target to $12.00

HC Wainwright decreased their target price on shares of Emergent Biosolutions from $15.00 to $12.00 and set a "buy" rating for the company in a research note on Monday...

Emergent Biosolutions (NYSE:EBS) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of Emergent Biosolutions from a "buy" rating to a "hold" rating in a report on Sunday...

Wall Street Zen Downgrades Emergent Biosolutions (NYSE:EBS) to Buy

Wall Street Zen cut shares of Emergent Biosolutions from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

Emergent Biosolutions Q4 Earnings Call Highlights

Emergent Biosolutions (NYSE:EBS) reported fourth-quarter and full-year 2025 results on a Feb. 26, 2026 earnings call, with management highlighting progress on its multi-year transformation plan...

<ul class="summary-bullets"><li>The company issues FY26 revenue guidance of $720 million-$760 million and Q1 guidance of $135 million-$155 million, both below consensus estimates.</li><li>Naloxone nasal spray revenues fell 41% due to rising competition, while anthrax biodefense product revenues rose 64% on delivery timing.</li><li>The company also announced new Canadian contracts worth up to C$140 million.</li></ul>Shares of Emergent BioSolutions, Inc. (EBS) fell over 20% in extended trading on Thursday after the company issued weaker-than-expected financial guidance for both the first quarter and full year 2026, overshadowing contract wins and a new stock buyback program.<a href="https://stocktwits.com/symbol/EBS">EBS stock</a> rose 0.8% in Thursday’s regular session.<h2 class="st-heading-2">Weak Outlook Weighs On Sentiment</h2>The biodefense company forecast full-year 2026 revenue in the range of $720 million to $760 million, below analysts’ consensus estimate of $809.4 million. The company also guided for first-quarter revenue of $135 million to $155 million, significantly below consensus expectations of $275 million.It also projected adjusted net income between $25 million and $45 million, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $135 million to $155 million."Our team remains focused on long-term sustainable value and achieving our vision of enabling several durable and profitable verticals in the Company over time," said CEO Joe Papa.<h2 class="st-heading-2">Earnings Miss Adds Pressure</h2>The cautious outlook came alongside weaker quarterly performance. Emergent reported a fourth-quarter (Q4) loss of $0.43 per share, compared with earnings of $0.05 per share a year earlier. Revenue came in at $148.7 million, missing expectations of $217.5 million.Naloxone product revenues from its opioid overdose reversal nasal sprays declined 41% due to increased competition. Anthrax medical countermeasure revenues, which include vaccines and treatments used for biodefense preparedness, rose 64%, driven by the timing of delivery. "Emergent's 2025 results demonstrate significant progress executing our multi-year turnaround strategy, delivering improved operating margins, strong adjusted EBITDA of $205 million, increased cash flow and lower leverage," Papa said.<h2 class="st-heading-2">Positive Developments Fail To Offset Concerns</h2>The company also announced new agreements worth up to C$140 million with the Canadian government agencies to supply medical countermeasures for biological threat preparedness. Emergent expects to receive more than C$35 million in orders from these contracts this year.Separately, the board authorized a new $50 million share repurchase program running through March 2027.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for EBS was ‘extremely bullish’ amid a 285% surge in 24-hour message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/ebs_ss_png_5927fdd04b.webp" alt="ebs ss.png" width="976" height="140"><figcaption>EBS sentiment and message volume as of February 27 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/ComradeKomisar/message/646069727">said</a>, “Pretty sure they 'sand bagged' the guidance, like they always do, and that order either will repeat, or we'll get it from Canada which can be threatned to lose the Winnipeg site, and move it to the US.”<stembedurl>https://stocktwits.com/ComradeKomisar/message/646069727</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Kawasaki1/message/646066600">said</a>, “Up 50 cents/ since the over reaction earlier...We were undervalued going into earnings and the future is still promising”<stembedurl>https://stocktwits.com/Kawasaki1/message/646066600</stembedurl>EBS stock has declined 10% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the Emergent BioSolutions logo of an US biopharmaceutical company is seen on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Why Did Emergent Biosolutions Stock Tumble 20% After-Hours Today?

The board authorized a new $50 million share repurchase program running through March 2027.

Equity

Emergent Biosolutions (NYSE:EBS) Releases Quarterly Earnings Results

Emergent Biosolutions (NYSE:EBS - Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.43) earnings per share (EPS) for the quarter, missing...

Emergent Biosolutions (EBS) Expected to Announce Earnings on Monday

Emergent Biosolutions (NYSE:EBS) will be releasing its Q4 2025 earnings after the market closes on Monday, March 2. (View Earnings Report at...

Emergent Biosolutions Inc. $EBS Shares Purchased by Allianz Asset Management GmbH

Allianz Asset Management GmbH grew its stake in shares of Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 149.0% during the 3rd quarter, according to the company in its most recent Form 13F...

New York State Common Retirement Fund Has $4.60 Million Stock Holdings in Emergent Biosolutions Inc. $EBS

New York State Common Retirement Fund lifted its stake in shares of Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 32.6% in the third quarter, according to its most recent Form 13F filing...

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above 200-Day Moving Average - Here's Why

Emergent Biosolutions (NYSE:EBS) Share Price Passes Above 200-Day Moving Average - Should You Sell...

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Current Price	$7.96
Prev Close	$8.45
Open	$8.40
Dividend Yield	0.00%
50-Day Moving Average	$9.38
Beta	2.07
Avg. Volume	1.01M
PE Ratio	9.59

52-Week High	$14.06
52-Week Low	$4.34
Market Capitalization	$411.09M
EPS (Annual)	$0.9277
Price to Book	0.79
Revenue Per Employee	$825,444.44

EBS
Emergent Biosolutions Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EBS News

EBSEmergent Biosolutions Inc